• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于适配体的癌细胞分析与治疗。

Aptamer-Based Cancer Cell Analysis and Treatment.

机构信息

Molecular Science and Biomedicine Laboratory (MBL), State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering College of Biology, Aptamer Engineering Center of Hunan Province, Hunan University, Changsha, Hunan, 410082, P. R. China.

Guangxi Key Laboratory of Electrochemical and Magnetochemical Function Materials, College of Chemistry and Bioengineering, Guilin University of Technology, Guilin, Guangxi, 541004, P. R. China.

出版信息

ChemistryOpen. 2022 Oct;11(10):e202200141. doi: 10.1002/open.202200141.

DOI:10.1002/open.202200141
PMID:36264016
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9583543/
Abstract

Aptamers are a class of single-stranded DNA or RNA oligonucleotides that can exclusively bind to various targets with high affinity and selectivity. Regarded as "chemical antibodies", aptamers possess several intrinsic advantages, including easy synthesis, convenient modification, high programmability, and good biocompatibility. In recent decades, many studies have demonstrated the superiority of aptamers as molecular tools for various biological applications, particularly in the area of cancer theranostics. In this review, we focus on recent progress in developing aptamer-based strategies for the precise analysis and treatment of cancer cells.

摘要

适配体是一类单链 DNA 或 RNA 寡核苷酸,能够专一地与各种靶标高亲和力和高选择性地结合。被称为“化学抗体”,适配体具有许多内在的优势,包括易于合成、方便修饰、高可编程性和良好的生物相容性。在最近几十年中,许多研究表明,适配体作为各种生物应用的分子工具具有优越性,特别是在癌症诊断和治疗领域。在这篇综述中,我们重点介绍了基于适配体的策略在精确分析和治疗癌细胞方面的最新进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/856c/9583543/9cdd8a2960fc/OPEN-11-e202200141-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/856c/9583543/212355ab5b2d/OPEN-11-e202200141-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/856c/9583543/cd75013803a2/OPEN-11-e202200141-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/856c/9583543/752156ea6d56/OPEN-11-e202200141-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/856c/9583543/e814a508dd22/OPEN-11-e202200141-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/856c/9583543/dcc7990575c0/OPEN-11-e202200141-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/856c/9583543/9cdd8a2960fc/OPEN-11-e202200141-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/856c/9583543/212355ab5b2d/OPEN-11-e202200141-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/856c/9583543/cd75013803a2/OPEN-11-e202200141-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/856c/9583543/752156ea6d56/OPEN-11-e202200141-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/856c/9583543/e814a508dd22/OPEN-11-e202200141-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/856c/9583543/dcc7990575c0/OPEN-11-e202200141-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/856c/9583543/9cdd8a2960fc/OPEN-11-e202200141-g003.jpg

相似文献

1
Aptamer-Based Cancer Cell Analysis and Treatment.基于适配体的癌细胞分析与治疗。
ChemistryOpen. 2022 Oct;11(10):e202200141. doi: 10.1002/open.202200141.
2
Progress in selection and biomedical applications of aptamers.适体的选择与生物医学应用进展。
J Biomed Nanotechnol. 2014 Oct;10(10):3043-62. doi: 10.1166/jbn.2014.1979.
3
SELEX methods on the road to protein targeting with nucleic acid aptamers.SELEX 方法在利用核酸适体进行蛋白质靶向中的应用。
Biochimie. 2018 Nov;154:132-155. doi: 10.1016/j.biochi.2018.09.001. Epub 2018 Sep 5.
4
Chimeric aptamers in cancer cell-targeted drug delivery.嵌合适体在癌细胞靶向药物递送中的应用。
Crit Rev Biochem Mol Biol. 2011 Dec;46(6):459-77. doi: 10.3109/10409238.2011.614592. Epub 2011 Sep 28.
5
Aptamer applications for targeted cancer therapy.适体在肿瘤靶向治疗中的应用。
Future Oncol. 2010 Jul;6(7):1117-26. doi: 10.2217/fon.10.67.
6
Advances of aptamers screened by Cell-SELEX in selection procedure, cancer diagnostics and therapeutics.通过细胞指数富集配体系统进化技术筛选的适体在筛选过程、癌症诊断与治疗中的进展。
Anal Biochem. 2020 Jun 1;598:113620. doi: 10.1016/j.ab.2020.113620. Epub 2020 Feb 19.
7
Aptamers: molecular tools for medical diagnosis.适配体:医学诊断的分子工具。
Curr Top Med Chem. 2015;15(12):1125-37. doi: 10.2174/1568026615666150413154233.
8
The development and testing of aptamers for cancer.用于癌症的适配体的开发与测试。
Curr Opin Investig Drugs. 2009 Jun;10(6):572-8.
9
Cancer biomarker discovery using DNA aptamers.利用DNA适配体发现癌症生物标志物。
Analyst. 2016 Jan 21;141(2):461-6. doi: 10.1039/c5an01918d.
10
Aptamer Selection for Detecting Molecular Target Using Cell-SELEX (Systematic Evolution of Ligands by Exponential Enrichment) Technology.使用细胞指数富集配体系统进化(Cell-SELEX)技术筛选用于检测分子靶标的适配体
Methods Mol Biol. 2019;2054:223-241. doi: 10.1007/978-1-4939-9769-5_15.

引用本文的文献

1
Recent Progress in DNA Biosensors: Target-Specific and Structure-Guided Signal Amplification.DNA生物传感器的最新进展:靶向特异性和结构导向的信号放大
Biosensors (Basel). 2025 Jul 23;15(8):476. doi: 10.3390/bios15080476.
2
CAR19-T/NK cell and circular aptamer-drug conjugate (ApDC) combination treatment increases immunotherapy efficacy.CAR19-T/NK细胞与环状适体-药物偶联物(ApDC)联合治疗可提高免疫治疗效果。
Mol Cell Biochem. 2025 Jul 13. doi: 10.1007/s11010-025-05347-3.
3
BiS/BiOCl heterojunction-based photoelectrochemical aptasensor for ultrasensitive assay of fumonisin B via signal amplification with in situ grown AgS quantum dots.

本文引用的文献

1
Efficient synthesis of artificial pharmaceutical solid-phase modules for constructing aptamer-drug conjugates.高效合成人工药物固相模块,用于构建适体-药物偶联物。
Bioorg Chem. 2022 Sep;126:105919. doi: 10.1016/j.bioorg.2022.105919. Epub 2022 Jun 1.
2
"Apollo Program" in Nanoscale: Landing and Exploring Cell-Surface with DNA Nanotechnology.纳米尺度下的“阿波罗计划”:利用DNA纳米技术登陆并探索细胞表面
ACS Appl Bio Mater. 2020 May 18;3(5):2723-2742. doi: 10.1021/acsabm.9b01193. Epub 2020 Mar 10.
3
Anti-MUC1/CD44 Dual-Aptamer-Conjugated Liposomes for Cotargeting Breast Cancer Cells and Cancer Stem Cells.
基于 BiS/BiOCl 异质结的光电化学适体传感器,通过原位生长的 AgS 量子点进行信号放大,用于伏马菌素 B 的超灵敏检测。
Mikrochim Acta. 2024 Nov 26;191(12):762. doi: 10.1007/s00604-024-06846-8.
4
Aptamers Versus Vascular Endothelial Growth Factor (VEGF): A New Battle against Ovarian Cancer.适体与血管内皮生长因子(VEGF):对抗卵巢癌的新战役。
Pharmaceuticals (Basel). 2023 Jun 6;16(6):849. doi: 10.3390/ph16060849.
5
Liposomes for Tumor Targeted Therapy: A Review.脂质体用于肿瘤靶向治疗:综述。
Int J Mol Sci. 2023 Jan 31;24(3):2643. doi: 10.3390/ijms24032643.
用于共靶向乳腺癌细胞和癌症干细胞的抗MUC1/CD44双适配体共轭脂质体
ACS Appl Bio Mater. 2019 Oct 21;2(10):4622-4633. doi: 10.1021/acsabm.9b00705. Epub 2019 Sep 11.
4
Isolation of DNA Aptamer Targeting PD-1 with an Antitumor Immunotherapy Effect.具有抗肿瘤免疫治疗作用的靶向程序性死亡受体1(PD-1)的DNA适配体的分离
ACS Appl Bio Mater. 2020 Oct 19;3(10):7080-7086. doi: 10.1021/acsabm.0c00919. Epub 2020 Oct 1.
5
Aptamer-Programmed DNA Nanodevices for Advanced, Targeted Cancer Theranostics.适体程序化 DNA 纳米器件用于先进的、靶向的癌症治疗诊断。
ACS Appl Bio Mater. 2021 Jul 19;4(7):5392-5404. doi: 10.1021/acsabm.1c00413. Epub 2021 Jun 18.
6
Aptamers: an emerging navigation tool of therapeutic agents for targeted cancer therapy.适配体:一种靶向癌症治疗的治疗药物的新兴导航工具。
J Mater Chem B. 2021 Dec 22;10(1):20-33. doi: 10.1039/d1tb02098f.
7
Smart Nanotherapeutics and Lung Cancer.智能纳米疗法与肺癌
Pharmaceutics. 2021 Nov 20;13(11):1972. doi: 10.3390/pharmaceutics13111972.
8
Aptamer-based biosensors and application in tumor theranostics.基于适配体的生物传感器及其在肿瘤诊疗中的应用。
Cancer Sci. 2022 Jan;113(1):7-16. doi: 10.1111/cas.15194. Epub 2021 Nov 16.
9
Lipid-oligonucleotide conjugates for bioapplications.用于生物应用的脂质 - 寡核苷酸缀合物。
Natl Sci Rev. 2020 Jul 9;7(12):1933-1953. doi: 10.1093/nsr/nwaa161. eCollection 2020 Dec.
10
Harnessing the immune system against cancer: current immunotherapy approaches and therapeutic targets.利用免疫系统对抗癌症:当前的免疫疗法方法和治疗靶点。
Mol Biol Rep. 2021 Dec;48(12):8075-8095. doi: 10.1007/s11033-021-06752-9. Epub 2021 Oct 20.